Allergy, Peanut
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients (NCT05695261) | Rima Rachid | 2023-06-08 |
| Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age (NCT05741476) | DBV Technologies | 2023-02-21 |
| Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts (NCT05432388) | Novartis Pharmaceuticals | 2022-10-12 |
| Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy (NCT04984876) | Novartis Pharmaceuticals | 2021-12-07 |
Track Allergy, Peanut automatically
Every clearance here is in the API, with alerts when new ones post.